Company Description

Ennaid Therapeutics is developing antiviral drugs to treat COVID-19 & other coronaviruses, Zika virus, dengue virus, and other mosquito-borne illnesses using proprietary peptide inhibitors that block the entry and replication of these viruses into healthy host cells.